GILEAD 4331 300 (Viread 300 mg)

Generic Name: tenofovir

Pill imprint GILEAD 4331 300 has been identified as Viread 300 mg.

Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GILEAD 4331 300

Viread 300 mg GILEAD 4331 300
Viread 300 mg GILEAD 4331 300
Viread 300 mg GILEAD 4331 300
Viread
Generic Name:
tenofovir
Imprint:
GILEAD 4331
300
Strength:
300 mg
Color:
Blue
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences
National Drug Code (NDC):
61958-0401
Inactive Ingredients:
corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
FD&C Blue No. 2
aluminum oxide
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5334 A S Medication Solutions LLC (repackager)
54868-4669 Physicians Total Care Inc (repackager)
68258-9003 Dispensing Solutions Inc. (repackager)
35356-0073 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)